NDA 019050 · Rising
Sufenta Preservative Free
Sufentanil Citrate · Injection
NovelPriority reviewLast checked: Nov 20, 2026Latest source record: Dec 22, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1984
May 4, 1984
Approved uses
2
Original approval plus efficacy supplements
Registered trials
460
51 Phase 3, 55 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Mar 19, 1993 Supplement 17 · Efficacy
- May 4, 1984 Original approval · Type 1 - New Molecular Entity · priority review
1 products under this application
- SUFENTA PRESERVATIVE FREE · SUFENTANIL CITRATE EQ 0.05MG BASE/ML · INJECTABLE, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Sufentanil" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
- Perioperative Dexmedetomidine and Long-term Survival After Cancer SurgeryPivotal-lookingRecruiting
Peking University First HospitalAcademic, hospital or other
NCT06030804 · 4,532 participants (planned) · Start Sep 12, 2023 · Primary completion Sep 2027
Drug: Dexmedetomidine; Placebo · For: Elderly; Cancer Surgery; Dexmedetomidine and 1 more
Sites: Hefei, China; Beijing, China; Chongqing, China · 40 sites in all
- Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal SurgeryPivotal-lookingCompleted
Xijing HospitalAcademic, hospital or other
NCT05576675 · 4,342 participants · Start May 1, 2018 · Primary completion Mar 31, 2022
Drug: sufentanil + nalbuphine; Sufentanil and 1 more · For: Gastrointestinal Surgery
Sites: XIan, China
- Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail PatientsPivotal-lookingRecruiting
Yongtao SunAcademic, hospital or other
NCT05635877 · 2,000 participants (planned) · Start Feb 7, 2023 · Primary completion Nov 30, 2026
Drug: Esmolol; Placebo Comparator: Placebo Comparator:normal saline(0.9%) · For: Frailty; Esmolol; Myocardial Injury
Sites: Jinan, China
- Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After SurgeryPivotal-lookingNot yet recruiting
Peking University First HospitalAcademic, hospital or other
NCT07576517 · 1,996 participants (planned) · Start Oct 2026 · Primary completion Dec 2029
Drug: Dex-Esk; Placebo · For: Older Patients; Surgery; Dexmedetomidine and 3 more
Sites: Beijing, China; Fuzhou, China; Shenzhen, China · 6 sites in all
- Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After SurgeryPivotal-lookingNot yet recruiting
Peking University First HospitalAcademic, hospital or other
NCT07576543 · 1,996 participants (planned) · Start Oct 2026 · Primary completion Dec 2030
Drug: Dex-Esk; Placebo · For: Older Patients; Surgery; Dexmedetomidine and 4 more
Sites: Beijing, China; Fuzhou, China; Shenzhen, China · 6 sites in all
- Etomidate to Improve Outcome in Elderly PatientsPivotal-lookingCompleted
Zhihong LUAcademic, hospital or other
NCT02910206 · 1,917 participants · Start Aug 15, 2017 · Primary completion Nov 20, 2019
Drug: Etomidate; propofol and 2 more · For: Postoperative Complications
Sites: Xi'an, China
- Epidural Anesthesia-analgesia and Long-term OutcomePivotal-lookingCompleted
Peking University First HospitalAcademic, hospital or other
NCT03012945 · 1,802 participants · Start Nov 1, 2014 · Primary completion Sep 30, 2019
Drug: Combined epidural-general anesthesia; General anesthesia · For: Elderly; Malignant Tumor; Surgical Resection and 2 more
Sites: Beijing, China · 5 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Comparison of Fentanyl, Remifentanil, Sufentanil and Alfentanil in Combination with Propofol for General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Sridharan K, Sivaramakrishnan G · Curr Clin Pharmacol 2019 · Comparative Study, Meta-Analysis
- Sufentanil for carboprost-induced adverse reactions during cesarean delivery under combined spinal-epidural anesthesia.
Hu Q, Guo J, Bai P, et al. · Ginekol Pol 2023 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Preventing postoperative cognitive dysfunction using anesthetic drugs in elderly patients undergoing noncardiac surgery: a systematic review and meta-analysis.
Zeng K, Long J, Li Y, et al. · Int J Surg 2023 · Systematic Review, Network Meta-Analysis
- Esketamine versus Sufentanil Applied Prior to Placement of Suspension Laryngoscope.
Zhang YY, Zhu S, Yang X, et al. · Laryngoscope 2023 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Effect of sufentanil on bispectral index in the elderly.
de Valence T, Elia N, Czarnetzki C, et al. · Anaesthesia 2018 · Randomized Controlled Trial
- Effect of flurbiprofen axetil on postoperative delirium for elderly patients.
Wang X, Wang Y, Hu Y, et al. · Brain Behav 2019 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Sponsor: Rising
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.